Analyst Price Targets — VERU
| Date | Analyst | Firm | Target | Price @ Post | Source | Headline |
|---|---|---|---|---|---|---|
| May 3, 2024 11:38 am | Yi Chen | H.C. Wainwright | $3.00 | $1.67 | TheFly | Veru price target raised to $3 from $2 at H.C. Wainwright |
| April 15, 2024 5:50 am | Leland Gershell | Oppenheimer | $5.00 | $1.52 | StreetInsider | Veru, Inc. (VERU) PT Lowered to $5 at Oppenheimer |
| December 7, 2022 6:28 am | — | H.C. Wainwright | $18.00 | $5.66 | Benzinga | HC Wainwright & Co. Maintains Buy on Veru, Lowers Price Target to $18 |
| April 15, 2022 11:26 am | Leland Gershell | Oppenheimer | $36.00 | $14.95 | Pulse 2.0 | Veru (VERU) Stock: $36 Price Target And Outperform Rating |
Latest News for VERU
MIAMI, FL, July 07, 2026 (GLOBE NEWSWIRE) -- Veru Inc. (NASDAQ: VERU), a late clinical stage biopharmaceutical company focused on developing innovative medicines for the treatment of cardiometabolic and inflammatory diseases, today announced it will present at the 2026 4th Annual Obesity & Weight Loss Drug Development Summit, and the Pre-Conference Workshop Day taking place on July 14-16, 2026, in Boston,…
Veru Inc. (VERU) Q2 2026 Earnings Call Prepared Remarks Transcript
--Phase 2b PLATEAU clinical study evaluating enobosarm + semaglutide is actively enrolling and on track for i nterim analysis first quarter calendar year 2027 —
MIAMI, FL, May 06, 2026 (GLOBE NEWSWIRE) -- Veru Inc. (NASDAQ: VERU), a late clinical stage biopharmaceutical company focused on developing innovative medicines for the treatment of cardiometabolic and inflammatory diseases, today announced it will host a conference call and audio webcast on Wednesday, May 13, 2026, at 8:00 a.m. ET to discuss its fiscal 2026 second quarter financial results and to provide a business…
Veru Inc. (NASDAQ: VERU - Get Free Report)'s stock price crossed below its 200-day moving average during trading on Thursday. The stock has a 200-day moving average of $2.64 and traded as low as $2.28. Veru shares last traded at $2.31, with a volume of 66,482 shares changing hands. Analyst Ratings Changes A number of
🧮 Earnings Move Analyzer
Insider Trading
Insider Trading
| Name | Role | Date | Type | Shares | Price | Form | Link |
|---|
Senate Trading
No Senate trades found for VERU.
U.S. House Trading
No House trades found for VERU.
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.